Star Imaging

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0YG001013
  • NSEID:
  • BSEID: 544482
INR
86.81
-0.7 (-0.8%)
BSENSE

Jan 19

BSE+NSE Vol: 21000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

21.0 k (-63.92%) Volume

Shareholding (Aug 2025)

FII

1.18%

Held by 3 FIIs

DII

10.48%

Held by 3 DIIs

Promoter

71.92%

How has been the historical performance of Star Imaging?

13-Nov-2025

Star Imaging has shown significant growth in shareholder's funds and total assets over the past four years, with shareholder's funds increasing to 47.15 Cr and total assets to 98.16 Cr by March 2025. Profit before tax improved to 21.00 Cr, although cash flow from operating activities turned negative, indicating potential cash generation challenges.

Answer:<BR>The historical performance of Star Imaging shows a significant increase in shareholder's funds and total assets over the past four years, with no standalone results declared. As of March 2025, shareholder's funds reached 47.15 Cr, up from 31.35 Cr in March 2024, and total assets also increased to 98.16 Cr from 81.64 Cr in the previous year. The company has seen a rise in total reserves, which grew to 33.65 Cr in March 2025 from 29.85 Cr in March 2024. Long-term borrowings decreased slightly to 14.87 Cr in March 2025 from 15.71 Cr in March 2024, while short-term borrowings increased to 17.86 Cr from 14.93 Cr in the same period. The profit before tax improved to 21.00 Cr in March 2025, compared to 16.00 Cr in March 2024, indicating a positive trend in profitability.<BR><BR>Breakdown:<BR>Star Imaging's financial metrics reflect a positive trajectory in its consolidated balance sheet and cash flow results. The company's shareholder's funds have shown a robust increase, rising from 18.36 Cr in March 2022 to 47.15 Cr in March 2025, while total assets have also grown significantly from 58.34 Cr to 98.16 Cr over the same period. Total reserves increased notably, indicating a strengthening financial position. Despite a slight decrease in long-term borrowings, short-term borrowings have risen, suggesting a shift in financing strategy. Profit before tax has improved markedly, moving from 0.00 Cr in March 2023 to 21.00 Cr in March 2025, showcasing enhanced operational performance. However, cash flow from operating activities turned negative in March 2025, indicating challenges in cash generation despite the overall growth in profitability.

View full answer

Is Star Imaging overvalued or undervalued?

04-Dec-2025

As of December 3, 2025, Star Imaging is considered overvalued with a valuation grade of expensive, a PE ratio of 13.80, and strong returns on capital, despite a recent stock price decline and better valuations compared to peers like Max Healthcare and Apollo Hospitals.

As of 3 December 2025, Star Imaging's valuation grade has moved from very expensive to expensive, indicating a slight improvement in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 13.80, an EV to EBITDA of 8.67, and a ROE of 33.81%. In comparison to peers, Max Healthcare has a significantly higher PE ratio of 74.7, while Apollo Hospitals is at 61.84, highlighting that Star Imaging's valuation is more reasonable yet still on the higher side.<BR><BR>Despite the recent decline in stock price, with a 1-month return of -14.81% compared to a Sensex return of 1.34%, the company's strong ROCE of 31.55% and a PEG ratio of 0.00 suggest that it is generating substantial returns on capital. However, given the overall market conditions and peer comparisons, Star Imaging remains overvalued in its current state.

View full answer

Why is Star Imaging and Path Lab Ltd falling/rising?

19-Jan-2026

As of 18-Jan, the stock price of Star Imaging and Path Lab Ltd is currently at Rs. 87.75, reflecting a 2.39% increase and a total return of 4.46% over the last three days, despite earlier volatility and a new 52-week low. The significant rise in delivery volume indicates increased investor interest in the stock.

As of 18-Jan, the stock price of Star Imaging and Path Lab Ltd is rising, currently at Rs. 87.75, which reflects an increase of Rs. 2.05 or 2.39%. This upward movement is notable as the stock has been gaining for the last three days, resulting in a total return of 4.46% during this period. Additionally, the stock has outperformed its sector by 3.35% today.<BR><BR>Despite opening with a loss of 6.07% and hitting a new 52-week low of Rs. 80.5 earlier in the day, the stock managed to reach an intraday high of Rs. 88.4, indicating a recovery from its lows. The increase in investor participation is also significant, with delivery volume rising by 254.17% compared to the 5-day average, suggesting heightened interest in the stock. <BR><BR>Overall, while the stock has experienced volatility, the recent gains and increased trading activity contribute to its rising price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 152 Cr (Micro Cap)

stock-summary
P/E

10.00

stock-summary
Industry P/E

61

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.59

stock-summary
Return on Equity

33.81%

stock-summary
Price to Book

3.25

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-32.18%
0%
-32.18%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Star Imaging for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Is Star Imaging overvalued or undervalued?

Valuation Metrics and Financial Performance

Star Imaging currently trades at a price-to-earnings (PE) ratio of approximately 13.8, which is notably lower than many of its healthcare sector peers. Its price-to-book value stands at 4.66, indicating that the market values the company at nearly five times its net asset value. The enterprise value to EBITDA ratio of 8.67 further suggests a moderate valuation relative to earnings before interest, tax, depreciation, and amortisation. These multiples place Star Imaging in the ‘expensive’ category, a downgrade from its previous ‘very expensive’ status as of early December 2025.

Importantly, Star Imaging boasts a strong return on capital employed (ROCE) of 31.55% and a return on equity (ROE) of 33.81%, signalling efficient use o...

Read full news article

Announcements stock-summary

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Central Electricity Regulatory Commission (CERC)

14-Jan-2026 | Source : BSE

Empanelment with Central Electricity Regulatory Commission (CERC)

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Indian Council Of Social Science Research (ICSSR)

13-Jan-2026 | Source : BSE

Empanelment with Indian Council of Social Science Research (ICSSR)

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Acceptance Of Request For Providing Credit/Cashless Medical Services To All Serving Officer(S)/Official(S) Of The Supreme Court Of India

07-Jan-2026 | Source : BSE

Acceptance of Request for providing Credit/Cashless facility to Officers/Officials of Supreme Court of India

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
6.00%
EBIT Growth (5y)
36.23%
EBIT to Interest (avg)
9.42
Debt to EBITDA (avg)
1.35
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
1.52
Tax Ratio
25.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.61%
ROCE (avg)
47.13%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
10
Industry P/E
61
Price to Book Value
3.25
EV to EBIT
7.66
EV to EBITDA
6.33
EV to Capital Employed
2.42
EV to Sales
2.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
31.55%
ROE (Latest)
33.81%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Aug 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (1.18%)

Promoter with highest holding

Pawan Gupta (51.7%)

Highest Public shareholder

Invicta Continuum Fund I (2.96%)

Individual Investors Holdings

11.01%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Star Imaging"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.19",
          "val2": "42.52",
          "chgp": "6.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.33",
          "val2": "11.70",
          "chgp": "48.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.12",
          "chgp": "16.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.08",
          "val2": "6.20",
          "chgp": "62.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.35%",
          "val2": "27.52%",
          "chgp": "10.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Star Imaging"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "83.24",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.51",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "2.50",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "15.91",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.25%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
45.19
42.52
6.28%
Operating Profit (PBDIT) excl Other Income
17.33
11.70
48.12%
Interest
1.30
1.12
16.07%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.08
6.20
62.58%
Operating Profit Margin (Excl OI)
38.35%
27.52%
10.83%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
83.24
NA
NA
Operating Profit (PBDIT) excl Other Income
28.51
NA
NA
Interest
2.50
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
15.91
NA
NA
Operating Profit Margin (Excl OI)
34.25%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Star Imaging and Path Lab Ltd stock-summary
stock-summary
Star Imaging and Path Lab Ltd
Micro Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available